1. Home
  2. HTBK vs SION Comparison

HTBK vs SION Comparison

Compare HTBK & SION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTBK
  • SION
  • Stock Information
  • Founded
  • HTBK 1997
  • SION 2019
  • Country
  • HTBK United States
  • SION United States
  • Employees
  • HTBK N/A
  • SION N/A
  • Industry
  • HTBK Major Banks
  • SION
  • Sector
  • HTBK Finance
  • SION
  • Exchange
  • HTBK Nasdaq
  • SION NYSE
  • Market Cap
  • HTBK 589.6M
  • SION 583.9M
  • IPO Year
  • HTBK 1998
  • SION 2025
  • Fundamental
  • Price
  • HTBK $9.54
  • SION $11.56
  • Analyst Decision
  • HTBK Buy
  • SION Strong Buy
  • Analyst Count
  • HTBK 3
  • SION 1
  • Target Price
  • HTBK $11.50
  • SION $32.00
  • AVG Volume (30 Days)
  • HTBK 333.7K
  • SION 245.8K
  • Earning Date
  • HTBK 04-24-2025
  • SION 03-20-2025
  • Dividend Yield
  • HTBK 5.45%
  • SION N/A
  • EPS Growth
  • HTBK N/A
  • SION N/A
  • EPS
  • HTBK 0.66
  • SION N/A
  • Revenue
  • HTBK $170,257,000.00
  • SION N/A
  • Revenue This Year
  • HTBK $10.79
  • SION N/A
  • Revenue Next Year
  • HTBK $5.03
  • SION N/A
  • P/E Ratio
  • HTBK $14.45
  • SION N/A
  • Revenue Growth
  • HTBK N/A
  • SION N/A
  • 52 Week Low
  • HTBK $7.66
  • SION $11.25
  • 52 Week High
  • HTBK $11.27
  • SION $25.19
  • Technical
  • Relative Strength Index (RSI)
  • HTBK 40.03
  • SION N/A
  • Support Level
  • HTBK $9.41
  • SION N/A
  • Resistance Level
  • HTBK $9.77
  • SION N/A
  • Average True Range (ATR)
  • HTBK 0.19
  • SION 0.00
  • MACD
  • HTBK -0.00
  • SION 0.00
  • Stochastic Oscillator
  • HTBK 32.50
  • SION 0.00

About HTBK Heritage Commerce Corp

Heritage Commerce Corp operates as a bank holding company. The company, through its subsidiary, offers commercial banking services to small and medium-sized businesses and their owners, managers, and employees. It operates through two segments, namely Banking and Factoring. The bank generates its revenue from the Banking segment.

About SION SIONNA THERAPEUTICS INC

Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which Heads to insufficient CFTR function.

Share on Social Networks: